#PersonalizedMedicine Archives

CSCO 2024 | Dr. Feng Shen: Witnessing CSCO’s Glorious Journey, Contributing to the Advancement of Personalized Surgical Treatment for Hepatobiliary Tu

By Peng Longmei 2024.10.27

Editor's Note: From September 25 to 29, 2024, the 27th National Clinical Oncology Conference and the 2024 CSCO Annual Academic Meeting, co-organized by the Chinese Society of Clinical Oncology (CSCO)…

Gut丨HBcrAg Levels Can Predict Chronic Hepatitis B Patients’ Response to Interferon Therapy

By Mourabit Halima 2024.09.01

Editor's Note The current treatment options for chronic hepatitis B (CHB) primarily include long-term nucleos(t)ide analogs (NA) therapy and short-term interferon therapy. Although these approaches can control viral replication to…

The Impact of CEBPA Mutations in Hematological Disorders: A Comprehensive Study

By Mourabit Halima 2024.03.17

Editor's note: Genetic mutations play a pivotal role in shaping the clinical presentation and prognosis of hematological disorders, with CEBPA mutations emerging as significant contributors to disease pathogenesis. This comprehensive…